Answers are grounded in this paper and cite their sources.
In post-COVID survivors, transforming growth factor-beta-1 (TGF-β1) might mediate fibroblast activation, resulting in persistent fibrosis.
No takes yet. Share an insight, caveat, or question.
Alfaro et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: